Aripiprazole Tablet
Product Images NDC 68071-3725

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 68071-3725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3725 3)

This text appears to be a label containing information about a medication named Aripiprazole 2mg. The label includes details such as lot numbers, quantity of tablets, manufacturer information, expiration date, and a warning to keep the medication out of reach of children and store it at a controlled temperature. It also provides a contact number for reporting side effects to the FDA and a reference number for the product.*

FDA Label Image

Aripiprazole-fig-16.jpg (Aripiprazole Fig 16)

FDA Label Image

Aripiprazole-fig-17 (Aripiprazole Fig 17)

This text appears to show data related to relapse rates for subjects in a study evaluating the medication Aripiprazole versus placebo. The numbers likely represent the number of subjects at risk over a certain period of time following randomization. The proportion of subjects experiencing relapse is provided as 0.1 for Aripiprazole and 0.0 for placebo. The days from randomization are also listed, indicating the time points at which the data was recorded.*

FDA Label Image

Effects Of Other Drugs On Dehydro-aripiprazole (Aripiprazole Fig10)

FDA Label Image

Effects Of Aripiprazole On Pharmacokinetics Of Other Drugs (Aripiprazole Fig11)

This is a statistical data table showing the fold change and 95% confidence intervals for a drug interaction study. The table displays the percentage change relative to a reference value without the interacting drug.*

FDA Label Image

Effects Of Intrinsic Factors On Aripiprazole (Aripiprazole Fig12)

FDA Label Image

Effects Of Intrinsic Factors On Dehydro-aripiprazole (Aripiprazole Fig13)

FDA Label Image

Effects Of Other Drugs On Aripiprazole (Aripiprazole Fig9)

FDA Label Image

Aripiprazole-fig-18 (Aripiprazole Fig 18)

FDA Label Image

Aripiprazole Structure (Aripiprazole Fig8)

FDA Label Image

Aripiprazole-graph (Aripiprazole Graph)

This text refers to a chart or table showing the proportion of subjects with relapse over the course of treatment with a specific drug (possibly "leviiprazole"). The data includes the number of subjects at risk on different days from randomization. The specific numbers seem to be related to the progression and outcomes of the treatment.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.